Royal Bank of Canada Reiterates “Outperform” Rating for Ardent Health Partners (NYSE:ARDT)

Royal Bank of Canada restated their outperform rating on shares of Ardent Health Partners (NYSE:ARDT) in a report published on Thursday,Benzinga reports. They currently have a $23.00 price objective on the stock.

ARDT has been the subject of several other reports. Leerink Partnrs upgraded Ardent Health Partners to a “strong-buy” rating in a research report on Monday, August 12th. KeyCorp began coverage on shares of Ardent Health Partners in a report on Friday, October 11th. They set an “overweight” rating and a $24.00 price objective for the company. Leerink Partners lifted their price target on shares of Ardent Health Partners from $23.00 to $25.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 12th. Loop Capital assumed coverage on shares of Ardent Health Partners in a research report on Monday, August 12th. They issued a “buy” rating and a $18.00 price objective for the company. Finally, Mizuho started coverage on Ardent Health Partners in a research note on Monday, August 12th. They set an “outperform” rating and a $20.00 price objective on the stock. Two equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $21.82.

Ardent Health Partners Stock Down 6.7 %

ARDT opened at $16.61 on Thursday. The stock’s fifty day simple moving average is $18.18. Ardent Health Partners has a 52 week low of $14.57 and a 52 week high of $20.72. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78.

Ardent Health Partners (NYSE:ARDT) last posted its quarterly earnings results on Wednesday, August 14th. The company reported $0.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.30 by $0.05. The company had revenue of $1.47 billion during the quarter, compared to the consensus estimate of $1.46 billion. As a group, research analysts predict that Ardent Health Partners will post 1.25 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Ardent Health Partners

Several institutional investors have recently bought and sold shares of ARDT. BNP Paribas Financial Markets bought a new position in shares of Ardent Health Partners during the 3rd quarter worth approximately $42,000. Financial Management Professionals Inc. acquired a new position in Ardent Health Partners during the third quarter worth $50,000. MetLife Investment Management LLC bought a new position in Ardent Health Partners in the third quarter valued at $135,000. Quadrature Capital Ltd acquired a new stake in Ardent Health Partners in the 3rd quarter valued at $229,000. Finally, Barclays PLC bought a new stake in Ardent Health Partners during the 3rd quarter worth about $385,000.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.